UCB reported EUR18.16B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Alcon AG USD 31.1B 521M Jun/2026
Almirall EUR 2.37B 29.97M Jun/2026
Amarin USD 634.08M 9.72M Sep/2026
argenx SE USD 10.03B 1.35B Jun/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Genmab DKK 12.52B 139M Jun/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GRIFOLS EUR 20.28B 191M Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lakefront Biotherapeutics EUR 3.35B 21.24M Jun/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.66B 975M Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Orion EUR 2.03B 160.3M Sep/2026
Recordati EUR 5.46B 89.21M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
UCB EUR 18.16B 971M Dec/2025
Unibail Rodamco EUR 49.68B 1.23B Dec/2025